TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea
· Delayed Price · Currency is KRW 3,145.00
+20.00 (0.64%)
Apr 2, 2025, 3:30 PM KST
TELCON RF PHARMACEUTICAL. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -26,320 | 13,906 | -42,084 | -23,098 | -40,893 | Upgrade
|
| Depreciation & Amortization | 4,507 | 4,244 | 4,281 | 4,200 | 4,397 | Upgrade
|
| Loss (Gain) From Sale of Assets | -17.27 | 14.8 | -34.38 | 250.45 | 195.64 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1,097 | 64.8 | 4,411 | 3,005 | 4,231 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1,275 | -13,466 | 13,146 | -4,626 | -9,010 | Upgrade
|
| Loss (Gain) on Equity Investments | 24,684 | -469.53 | 17,868 | 13,196 | 39,204 | Upgrade
|
| Provision & Write-off of Bad Debts | 206.34 | 251.8 | 746.56 | -19.19 | -2,915 | Upgrade
|
| Other Operating Activities | 618.75 | 963.05 | 2,648 | 7,383 | 3,557 | Upgrade
|
| Change in Accounts Receivable | -3,908 | -6,563 | -1,450 | -791.38 | 6,131 | Upgrade
|
| Change in Inventory | 528.74 | -717.74 | -1,684 | -677.17 | -199.08 | Upgrade
|
| Change in Accounts Payable | 1,572 | 503.37 | 646.52 | 60.21 | 136.69 | Upgrade
|
| Change in Other Net Operating Assets | -474.55 | 133.25 | -586.66 | 758.06 | -2,033 | Upgrade
|
| Operating Cash Flow | 1,219 | -1,135 | -2,093 | -358.56 | 2,803 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -44.09% | Upgrade
|
| Capital Expenditures | -4,968 | -3,820 | -819.43 | -2,254 | -1,132 | Upgrade
|
| Sale of Property, Plant & Equipment | 18.05 | 5.88 | 66.81 | 60.24 | 196.69 | Upgrade
|
| Sale (Purchase) of Intangibles | -7.13 | -18 | -14.52 | -3,559 | -3,485 | Upgrade
|
| Investment in Securities | -44,536 | 419.38 | -7,082 | 6,508 | -57,921 | Upgrade
|
| Other Investing Activities | 38.83 | -32.32 | 46.34 | 124.26 | 237.14 | Upgrade
|
| Investing Cash Flow | -44,084 | -10,525 | -7,885 | 879.02 | -62,078 | Upgrade
|
| Short-Term Debt Issued | 36,600 | - | 200 | - | - | Upgrade
|
| Long-Term Debt Issued | 29,780 | 13,108 | 1,000 | - | 81,211 | Upgrade
|
| Total Debt Issued | 66,380 | 13,108 | 1,200 | - | 81,211 | Upgrade
|
| Short-Term Debt Repaid | -18,000 | -200 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -10,737 | -2,947 | -4,640 | -1,922 | -12,968 | Upgrade
|
| Total Debt Repaid | -28,737 | -3,147 | -4,640 | -1,922 | -12,968 | Upgrade
|
| Net Debt Issued (Repaid) | 37,643 | 9,961 | -3,440 | -1,922 | 68,243 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 66.22 | Upgrade
|
| Other Financing Activities | 8.55 | 484.74 | - | 31.01 | 17.73 | Upgrade
|
| Financing Cash Flow | 37,651 | 10,445 | -3,440 | -1,891 | 68,327 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.6 | -0.46 | -43.32 | 24.42 | -10.58 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | -226.56 | Upgrade
|
| Net Cash Flow | -5,213 | -1,214 | -13,462 | -1,346 | 8,814 | Upgrade
|
| Free Cash Flow | -3,749 | -4,954 | -2,912 | -2,613 | 1,671 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -58.80% | Upgrade
|
| Free Cash Flow Margin | -9.90% | -13.64% | -10.46% | -6.90% | 5.04% | Upgrade
|
| Free Cash Flow Per Share | -316.87 | -331.29 | -212.06 | -297.40 | 195.25 | Upgrade
|
| Cash Interest Paid | 1,304 | 553.73 | 861.4 | 2,419 | 613.83 | Upgrade
|
| Cash Income Tax Paid | 200.01 | 45.14 | -27.4 | 40.1 | 21.13 | Upgrade
|
| Levered Free Cash Flow | 10,349 | -5,322 | 316 | -7,715 | -1,038 | Upgrade
|
| Unlevered Free Cash Flow | 12,699 | -4,945 | 980.21 | -2,901 | 742.05 | Upgrade
|
| Change in Net Working Capital | -13,211 | 5,955 | -72.07 | -1,564 | -2,268 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.